Go Pro
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$154.13 -9.81 (-5.99%)
As of 12:06 PM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Advanced

Key Stats

Today's Range
$154.13
▼
$163.61
50-Day Range
$149.97
▼
$170.60
52-Week Range
$116.68
▼
$175.56
Volume
76 shs
Average Volume
632 shs
Market Capitalization
$19.92 billion
P/E Ratio
23.53
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world's oldest operating pharmaceutical and chemical companies. Merck KGaA is separate from the U.S.-based Merck & Co., Inc., although the two companies share historical roots.

The company operates through three business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, chemicals and bioprocessing technologies used by pharmaceutical, biotechnology and academic customers. Healthcare develops and markets prescription medicines and products in areas including oncology, immunology, neurology, fertility and endocrinology.

Merck KGaA's Electronics business provides specialty materials and solutions for the semiconductor and display industries, including materials used in chip manufacturing, liquid-crystal and OLED displays, and other advanced electronic applications. The company serves customers in markets around the world through a broad international research, manufacturing and commercial network.

Merck KGaA is led by Belén Garijo, who has served as chair of the company's Executive Board and chief executive officer since 2021. The company remains closely associated with the Merck family, whose investment vehicle, E. Merck KG, is its long-term majority shareholder.

AI Generated. May Contain Errors.

Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKGAF Stock News Headlines

Legendary U.S. Congressman Issues Warning
Dr. Ron Paul warns a dangerous experiment is already underway in Washington, involving at least 27 billion dollars and roughly 30 U.S. companies. Some stocks tied to this shift have already fallen 50% or more, Paul says, as the relationship between government and the stock market changes.tc pixel
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $147.60 at the beginning of the year. Since then, MKGAF shares have increased by 11.1% and is now trading at $163.94.

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/30/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,461
Year Founded
1891

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
23.53
Forward P/E Ratio
15.81
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.88
Cash Flow
$46.42 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.73

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$19.92 billion
Optionable
Not Optionable
Beta
0.96

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners